Exploring the Role and Mechanisms of MAGEA4 in Tumorigenesis, Regulation, and Immunotherapy

Overview

Journal Mol Med

Publisher Biomed Central

Date 2025 Feb 5

PMID 39905312

Authors

Weijian Zhu

Qiang Yi

Zheng Chen

Jiaqi Wang

Kui Zhong

Xinting Ouyang

Kuan Yang

Bowei Jiang

Jianing Zhong

Jinghua Zhong

Affiliations

Soon will be listed here.

Abstract

MAGEA4 is a member of the Melanoma-Associated Antigen (MAGE) family, characterized by high expression in various tumor tissues but low expression in normal tissues, with the exception of testis and placenta. Its expression is associated with poor prognosis in cancer. This review summarizes the mechanisms of action, regulatory functions, and immunotherapeutic applications of MAGEA4 in cancer.MAGEA4 promotes tumor initiation and progression through multiple pathways, including ubiquitination and degradation of the tumor suppressor P53, regulation of cell cycle and apoptosis, modulation of DNA damage repair, and enhancement of cancer cell survival. By forming a complex with TRIM28, MAGEA4 accelerates tumor development via P53 degradation. Factors such as TWIST1 and BORIS can upregulate MAGEA4 expression. MAGEA4 interacts with proteins including Miz-1, p53, and RAD18, participating in gene transcription regulation and DNA damage repair. By stabilizing RAD18, MAGEA4 facilitates the recruitment of Y-family DNA polymerases, enabling cells to continue replication under DNA damage conditions and thus supporting cancer cell survival. MAGEA4-based TCR-T cell therapy and cancer vaccines show clinical potential. This article comprehensively reviews the structure and function of MAGEA4, as well as recent research progress in solid tumors, providing a theoretical foundation for the clinical translation of MAGEA4 and its application in immunotherapy.

References

Peng J, Chen H, Mou D, Cao J, Cong X, Qin L . Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Cancer Lett. 2005; 219(2):223-32. DOI: 10.1016/j.canlet.2004.07.028. View

Prasad M, Jungbluth A, Patel S, Iversen K, Hoshaw-Woodard S, Busam K . Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Head Neck. 2004; 26(12):1053-7. DOI: 10.1002/hed.20112. View

Vogelstein B, Lane D, Levine A . Surfing the p53 network. Nature. 2000; 408(6810):307-10. DOI: 10.1038/35042675. View

Hosono S, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A . Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer. 2007; 96(2):314-20. PMC: 2360014. DOI: 10.1038/sj.bjc.6603533. View

Ellis R, Weiss A . Human Vaccines & Immunotherapeutics: News May 2022. Hum Vaccin Immunother. 2022; 18(5):2087405. PMC: 9621072. DOI: 10.1080/21645515.2022.2087405. View

Peng H, Begg G, Schultz D, Friedman J, Jensen D, Speicher D . Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J Mol Biol. 2000; 295(5):1139-62. DOI: 10.1006/jmbi.1999.3402. View

Gao Y, Mutter-Rottmayer E, Greenwalt A, Goldfarb D, Yan F, Yang Y . A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. Nat Commun. 2016; 7:12105. PMC: 4935975. DOI: 10.1038/ncomms12105. View

Hussein Y, Morad F, Gameel M, Emam W, El Sawy W, El Tarhouny S . MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients. Med Oncol. 2012; 29(5):3055-62. DOI: 10.1007/s12032-012-0257-1. View

Ueda S, Miyahara Y, Nagata Y, Sato E, Shiraishi T, Harada N . NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma. Oncotarget. 2018; 9(89):35997-36011. PMC: 6267599. DOI: 10.18632/oncotarget.26323. View

10.

Pande P, Haraguchi K, Jiang Y, Greenberg M, Basu A . Unlike catalyzing error-free bypass of 8-oxodGuo, DNA polymerase λ is responsible for a significant part of Fapy·dG-induced G → T mutations in human cells. Biochemistry. 2015; 54(10):1859-62. PMC: 4630799. DOI: 10.1021/acs.biochem.5b00119. View

11.

Park J, Jeon C, Lee K, Chang H . Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans. J Korean Med Sci. 2002; 17(4):497-501. PMC: 3054906. DOI: 10.3346/jkms.2002.17.4.497. View

12.

Cabezon T, Gromova I, Gromov P, Serizawa R, Wielenga V, Kroman N . Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer. Mol Cell Proteomics. 2012; 12(2):381-94. PMC: 3567861. DOI: 10.1074/mcp.M112.019786. View

13.

Martinez L, Yang J, Vazquez E, Olive M, Hsieh J, Logothetis C . p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells. Carcinogenesis. 2002; 23(8):1289-96. DOI: 10.1093/carcin/23.8.1289. View

14.

Forghanifard M, Rad A, Farshchian M, Khaleghizadeh M, Gholamin M, Moghbeli M . TWIST1 upregulates the MAGEA4 oncogene. Mol Carcinog. 2016; 56(3):877-885. DOI: 10.1002/mc.22541. View

15.

Engeland K . Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022; 29(5):946-960. PMC: 9090780. DOI: 10.1038/s41418-022-00988-z. View

16.

Lv L, Wang F, Ma X, Yang Y, Wang Z, Liu H . Mismatch repair protein MSH2 regulates translesion DNA synthesis following exposure of cells to UV radiation. Nucleic Acids Res. 2013; 41(22):10312-22. PMC: 3905884. DOI: 10.1093/nar/gkt793. View

17.

Alves P, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M . Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother. 2006; 56(6):839-47. PMC: 11030638. DOI: 10.1007/s00262-006-0228-5. View

18.

Chen X, Wang L, Yue D, Liu J, Huang L, Yang L . Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma. Histol Histopathol. 2016; 32(8):793-803. DOI: 10.14670/HH-11-847. View

19.

Abbasi Sani S, Forghanifard M, Sharifi N, Bidokhti M, Bagherpoor A, Abbaszadegan M . Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma. J Cancer Res Ther. 2018; 14(5):1059-1064. DOI: 10.4103/0973-1482.183180. View

20.

Herrera L . Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2021; 22(5):1495-1506. PMC: 8408400. DOI: 10.31557/APJCP.2021.22.5.1495. View